Literature DB >> 18318461

Unnatural amino acid incorporation into virus-like particles.

Erica Strable1, Duane E Prasuhn, Andrew K Udit, Steven Brown, A James Link, John T Ngo, Gabriel Lander, Joel Quispe, Clinton S Potter, Bridget Carragher, David A Tirrell, M G Finn.   

Abstract

Virus-like particles composed of hepatitis B virus (HBV) or bacteriophage Qbeta capsid proteins have been labeled with azide- or alkyne-containing unnatural amino acids by expression in a methionine auxotrophic strain of E. coli. The substitution does not affect the ability of the particles to self-assemble into icosahedral structures indistinguishable from native forms. The azide and alkyne groups were addressed by Cu(I)-catalyzed [3 + 2] cycloaddition: HBV particles were decomposed by the formation of more than 120 triazole linkages per capsid in a location-dependent manner, whereas Qbeta suffered no such instability. The marriage of these well-known techniques of sense-codon reassignment and bioorthogonal chemical coupling provides the capability to construct polyvalent particles displaying a wide variety of functional groups with near-perfect control of spacing.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18318461      PMCID: PMC2713011          DOI: 10.1021/bc700390r

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  70 in total

1.  EMAN: semiautomated software for high-resolution single-particle reconstructions.

Authors:  S J Ludtke; P R Baldwin; W Chiu
Journal:  J Struct Biol       Date:  1999-12-01       Impact factor: 2.867

2.  Proteins with beta-(thienopyrrolyl)alanines as alternative chromophores and pharmaceutically active amino acids.

Authors:  N Budisa; S Alefelder; J H Bae; R Golbik; C Minks; R Huber; L Moroder
Journal:  Protein Sci       Date:  2001-07       Impact factor: 6.725

3.  Adaptation of an orthogonal archaeal leucyl-tRNA and synthetase pair for four-base, amber, and opal suppression.

Authors:  J Christopher Anderson; Peter G Schultz
Journal:  Biochemistry       Date:  2003-08-19       Impact factor: 3.162

4.  Hepatitis core antigen produced in Escherichia coli: subunit composition, conformational analysis, and in vitro capsid assembly.

Authors:  P T Wingfield; S J Stahl; R W Williams; A C Steven
Journal:  Biochemistry       Date:  1995-04-18       Impact factor: 3.162

5.  Assembly of bacteriophage Qbeta virus-like particles in yeast Saccharomyces cerevisiae and Pichia pastoris.

Authors:  Janis Freivalds; Andris Dislers; Velta Ose; Dace Skrastina; Indulis Cielens; Paul Pumpens; Kestutis Sasnauskas; Andris Kazaks
Journal:  J Biotechnol       Date:  2006-01-06       Impact factor: 3.307

6.  Presentation and detection of azide functionality in bacterial cell surface proteins.

Authors:  A James Link; Mandy K S Vink; David A Tirrell
Journal:  J Am Chem Soc       Date:  2004-09-01       Impact factor: 15.419

7.  Preparation of the functionalizable methionine surrogate azidohomoalanine via copper-catalyzed diazo transfer.

Authors:  A James Link; Mandy K S Vink; David A Tirrell
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

8.  Bio-distribution, toxicity and pathology of cowpea mosaic virus nanoparticles in vivo.

Authors:  Pratik Singh; Duane Prasuhn; Robert M Yeh; Giuseppe Destito; Chris S Rae; Kent Osborn; M G Finn; Marianne Manchester
Journal:  J Control Release       Date:  2007-04-13       Impact factor: 9.776

9.  Azidoalanine mutagenicity in Salmonella: effect of homologation and alpha-methyl substitution.

Authors:  J B Mangold; M R Mischke; J M LaVelle
Journal:  Mutat Res       Date:  1989-02       Impact factor: 2.433

10.  A strain-promoted [3 + 2] azide-alkyne cycloaddition for covalent modification of biomolecules in living systems.

Authors:  Nicholas J Agard; Jennifer A Prescher; Carolyn R Bertozzi
Journal:  J Am Chem Soc       Date:  2004-11-24       Impact factor: 15.419

View more
  48 in total

Review 1.  Choosing an effective protein bioconjugation strategy.

Authors:  Nicholas Stephanopoulos; Matthew B Francis
Journal:  Nat Chem Biol       Date:  2011-11-15       Impact factor: 15.040

Review 2.  Residue-specific incorporation of non-canonical amino acids into proteins: recent developments and applications.

Authors:  Jeremiah A Johnson; Ying Y Lu; James A Van Deventer; David A Tirrell
Journal:  Curr Opin Chem Biol       Date:  2010-11-09       Impact factor: 8.822

3.  A potential nanobiotechnology platform based on infectious bursal disease subviral particles.

Authors:  Omid Taghavian; Manoj K Mandal; Nicole F Steinmetz; Stefan Rasche; Holger Spiegel; Rainer Fischer; Stefan Schillberg
Journal:  RSC Adv       Date:  2012-01-09       Impact factor: 3.361

4.  Engineered virus-like nanoparticles reverse heparin anticoagulation more consistently than protamine in plasma from heparin-treated patients.

Authors:  Andrew J Gale; Darlene J Elias; Patricia M Averell; Paul S Teirstein; Mitchell Buck; Steven D Brown; Zinaida Polonskaya; Andrew K Udit; M G Finn
Journal:  Thromb Res       Date:  2011-04-14       Impact factor: 3.944

5.  Nanoparticles: designer labels for virus coats.

Authors:  Isaac S Carrico; Kent Kirshenbaum
Journal:  Nat Nanotechnol       Date:  2009-01       Impact factor: 39.213

6.  Site-Specific Protein Bioconjugation via a Pyridoxal 5'-Phosphate-Mediated N-Terminal Transamination Reaction.

Authors:  Leah S Witus; Matthew Francis
Journal:  Curr Protoc Chem Biol       Date:  2010-06-01

Review 7.  The art of engineering viral nanoparticles.

Authors:  Jonathan K Pokorski; Nicole F Steinmetz
Journal:  Mol Pharm       Date:  2010-12-17       Impact factor: 4.939

8.  Surface functionalization of virus-like particles by direct conjugation using azide-alkyne click chemistry.

Authors:  Kedar G Patel; James R Swartz
Journal:  Bioconjug Chem       Date:  2011-02-28       Impact factor: 4.774

Review 9.  Virus-Based Nanoparticles as Versatile Nanomachines.

Authors:  Kristopher J Koudelka; Andrzej S Pitek; Marianne Manchester; Nicole F Steinmetz
Journal:  Annu Rev Virol       Date:  2015-09-25       Impact factor: 10.431

10.  2G12-expressing B cell lines may aid in HIV carbohydrate vaccine design strategies.

Authors:  Katie J Doores; Michael Huber; Khoa M Le; Sheng-Kai Wang; Colleen Doyle-Cooper; Anthony Cooper; Ralph Pantophlet; Chi-Huey Wong; David Nemazee; Dennis R Burton
Journal:  J Virol       Date:  2012-12-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.